Trial Profile
A Phase 1 Study to Assess the Pharmacokinetics of Nitrates and Gamma-Hydroxybutyric Acid (GHB) After Oral Administration of Therapeutic and Supratherapeutic Doses of Naproxcinod in Healthy Male Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Naproxcinod (Primary)
- Indications Arthritis
- Focus Pharmacokinetics
- Sponsors NicOx
- 01 Aug 2011 New trial record